Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events
Ezetimibe is a relatively new drug that inhibits the absorption of dietary cholesterol in the small intestine. It is an LDL-cholesterol lowering medication that acts directly on the intestine by inhibiting Niemann-Pick C1 Like1 (NPC1L1). Recently, results of the ARBITER 6-HALTS trial (Arterial Biolo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2010-11.
|
| Subjects: | |
| Online Access: | Get fulltext |